RxDoctor Payments Data

Joycelyn Schindler, MD

Obstetrics & Gynecology · Little River, SCNPI 1750540118

Payments from drug & device makers

$4,883in general payments, 2019–2025

Across 211 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Astellas Pharma US Inc$718
  • Optumhealth Care Solutions, LLC$573
  • Sumitomo Pharma America, Inc.$248
  • Myovant Sciences Inc.$245
  • Pfizer$161
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$4,44791%
  • Education$4369%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,883 in reported general payments places this provider in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.

See all obstetrics & gynecology providers in South Carolina

Medicare billing

Part B allowed, 2024
$66,593
Medicare patients
443
Services billed
901

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide37$38,131
OzempicSemaglutide24$27,317
GemtesaVibegron19$15,391
MyrbetriqMirabegron17$13,931
PremarinEstrogens, Conjugated29$12,850
PremproEstrogen,con/M-Progest Acet14$9,267
Estradiol229$8,312
Estradiol (Once Weekly)Estradiol26$2,810
ValacyclovirValacyclovir Hcl69$2,513
Estradiol (Twice Weekly)Estradiol23$2,187
YuvafemEstradiol11$2,106
Clobetasol Propionate92$1,925
Acyclovir12$725
Fluconazole70$538
Medroxyprogesterone Acetate33$515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$127$38,13137 claims
Novo NordiskOzempic$34$27,31724 claims
PfizerPremarin, Prempro$161$22,11843 claims
Sumitomo Pharma America, Inc.Gemtesa$248$15,39119 claims
Astellas Pharma US IncMyrbetriq$718$13,93117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.

Other obstetrics & gynecology in Little River

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →